Shumei Meng
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 5%
- Surgery top 10%
- Physiology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- R. Davis ManningGarrick W. CasonLing HeNiu TianFredric E. WondisfordSally RadovickJia CaoEvan Chang
- Topics
- Metabolism, Diabetes, and Cancer (10 papers)Pancreatic function and diabetes (10 papers)Diabetes Treatment and Management (8 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Shumei Meng
27 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 431
- Endocrinology, Diabetes and Metabolism 430
- Surgery 366
- Physiology 329
- Cardiology and Cardiovascular Medicine 242
Countries citing papers authored by Shumei Meng
This map shows the geographic impact of Shumei Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shumei Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shumei Meng more than expected).
Fields of papers citing papers by Shumei Meng
This network shows the impact of papers produced by Shumei Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shumei Meng. The network helps show where Shumei Meng may publish in the future.
Co-authorship network of co-authors of Shumei Meng
This figure shows the co-authorship network connecting the top 25 collaborators of Shumei Meng. A scholar is included among the top collaborators of Shumei Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shumei Meng. Shumei Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 46 | |
| 7 | 82 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 45 | |
| 11 | 20 | |
| 12 | 117 | |
| 13 | The Anticancer Effect of Metformin, the Most Commonly Used Anti-Diabetes Drug | 4 |
| 14 | 44 | |
| 15 | 43 | |
| 16 | 148 | |
| 17 | 149 | |
| 18 | 1 | |
| 19 | 43 | |
| 20 | 53 |
About Shumei Meng
Shumei Meng is a scholar working on Endocrinology, Diabetes and Metabolism, Transplantation and Emergency Medical Services, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (10 papers), Pancreatic function and diabetes (10 papers) and Diabetes Treatment and Management (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (430 citations), Transplantation (67 citations) and Biochemistry (115 citations). Shumei Meng has collaborated with scholars based in United States, Germany and China. Frequent co-authors include R. Davis Manning, Garrick W. Cason, Ling He, Niu Tian, Fredric E. Wondisford, Sally Radovick, Jia Cao, Evan Chang, Anthony W. Gannon and Lorraine C. Racusen. Their work appears in journals such as Journal of Biological Chemistry, Hypertension and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.